Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Researchers score $2M to examine side effects of radiation therapy in prostate cancer patients

The grant will fund a team at the UCLA Health Jonsson Comprehensive Cancer Center working to identify genetic biomarkers capable of predicting RT side effects.

How much is too much when it comes to cryoablation volumes in solitary kidneys?

A paper in the Journal of Vascular and Interventional Radiology offers new guidance on how ablation volumes affect renal function in solitary kidneys and highlights ranges that pose the least risk to patients.

Blood pressure drug could make leukemia more responsive to chemotherapy

“This finding shows great potential to enhance the success of chemotherapy while protecting the heart," one researcher said.

In a national survey, 89% of cancer centers report drug shortages

Respondents said supply chain issues are running afoul of prior authorization requirements, leading to delays in patient care.

Fluorinated contrast agents show 'strong potential' for MRI theranostics

Experts have developed a first-of-its-kind fluorinated contrast agent they believe will provide more detailed MR imaging and aid in the treatment of certain cancers.

colorectal cancer colon CTC CRC colonoscopy

Radiology's role in colorectal cancer care set to grow following 'groundbreaking' trial results

The results were so conclusive that the trial was halted at halftime for having met predefined stopping rules.

Lung cancer screening CT image in a 66-year-old male patient shows a sessile nodule with internal air in the left mainstem to left upper lobe bronchus (arrow) with a mean diameter of 10 mm. The nodule was assigned as Lung-RADS category 4A in the clinical report. (B) Follow-up CT image shows the lesion is resolved. Image courtesy of RSNA

Lung-RADS update helps limit false-positive results, unnecessary procedures

Using the latest version was associated with improved diagnostic accuracy, researchers wrote in a new analysis.

time-delayed MRI phases improve brain tumor visualization

Using multiple MRI phases after contrast injection significantly improves visualization of brain tumors

Researchers are proposing making additional phases beyond the 10-minute mark mandatory when analyzing brain metastases.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care